Mark A. Kroenke
Amgen (United States)(US)
Publications by Year
Research Areas
T-cell and B-cell Immunology, Biosimilars and Bioanalytical Methods, Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, Immunotherapy and Immune Responses
Most-Cited Works
- → Human Circulating PD-1+CXCR3−CXCR5+ Memory Tfh Cells Are Highly Functional and Correlate with Broadly Neutralizing HIV Antibody Responses(2013)883 cited
- → IL-12– and IL-23–modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition(2008)578 cited
- → Bcl6 and Maf Cooperate To Instruct Human Follicular Helper CD4 T Cell Differentiation(2012)335 cited
- → The Th17–ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune disease(2008)269 cited
- → BCL6 orchestrates Tfh cell differentiation via multiple distinct mechanisms(2015)246 cited
- → GM-CSF–dependent, CD103+ dermal dendritic cells play a critical role in Th effector cell differentiation after subcutaneous immunization(2010)192 cited
- → EAE mediated by a non‐IFN‐γ/non‐IL‐17 pathway(2010)100 cited
- → Immunogenicity assessment of bispecific antibody-based immunotherapy in oncology(2022)78 cited
- → Assay format diversity in pre-clinical immunogenicity risk assessment: Toward a possible harmonization of antigenicity assays(2021)54 cited
- → Th17 and Th1 responses directed against the immunizing epitope, as opposed to secondary epitopes, dominate the autoimmune repertoire during relapses of experimental autoimmune encephalomyelitis(2007)44 cited